This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reply to: Comment on: "Premedication prior to PEG‐asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia". Issue 11 (26th March 2022)
Record Type:
Journal Article
Title:
Reply to: Comment on: "Premedication prior to PEG‐asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia". Issue 11 (26th March 2022)
Main Title:
Reply to: Comment on: "Premedication prior to PEG‐asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia"